“Serial ferritin titer” monitoring in COVID-19 pneumonia: valuable inflammatory marker in assessment of severity and predicting early lung fibrosis — prospective, multicentric, observational, and interventional study in tertiary care setting in India

Springer Science and Business Media LLC - Tập 34 - Trang 1-10 - 2022
Shital Patil1, Gajanan Gondhali2, Abhijit Acharya3
1Pulmonary Medicine, MIMSR Medical College, Latur, India
2Internal Medicine, MIMSR Medical College, Latur, India
3Department of Pathology, MIMSR Medical College, Latur, India

Tóm tắt

The COVID-19 pneumonia is a heterogeneous disease with variable effect on lung parenchyma, airways, and vasculature leading to long-term effects on lung functions. Multicentric, prospective, observational, and interventional study conducted during July 2020 to May 2021, in the MIMSR Medical College and Venkatesh Hospital Latur India, included 1000 COVID-19 cases confirmed with RT-PCR. All cases were assessed with lung involvement documented and categorized on HRCT thorax, oxygen saturation, inflammatory marker, ferritin at entry point, and follow-up during hospitalization. Age, gender, comorbidity, and use of BIPAP/NIV and outcome as with or without lung fibrosis as per CT severity were key observations. CT severity scoring is done as per universally accepted standard scoring tool as score < 7 as mild, 7–14 as moderate, and score > 15 as severe affection of the lung. Statistical analysis is done by using chi-square test. In study of 1000 COVID-19 pneumonia cases, age (< 50 and > 50 years) and gender (male versus female) have significant association with ferritin in predicting severity of COVID-19 pneumonia (p < 0.00001) and (p < 0.010), respectively. CT severity score at entry point with ferritin level has significant correlation in severity scores < 8, 8–15, and > 15 documented in normal and abnormal ferritin level as in 190/110, 90/210, and 40/360, respectively (p < 0.00001). Ferritin level has significant association with duration of illness, i.e., DOI < 7 days, 8–15 days, and > 15 days of onset of symptoms documented normal and abnormal ferritin levels in 30/310, 160/300, and 130/70 cases, respectively (p < 0.00001). Comorbidity as diabetes mellitus, hypertension, COPD, IHD, and obesity has significant association in COVID-19 cases with normal and abnormal ferritin level respectively (p < 0.00001). Ferritin level has significant association with oxygen saturation in COVID-19 pneumonia cases; cases with oxygen saturation > 90%, 75–90%, and < 75% are observed as normal and abnormal ferritin level in 110/100, 150/340, and 60/240 cases, respectively (p < 0.00001). BIPAP/NIV requirement during the course of COVID-19 pneumonia in critical care setting has significant association with ferritin level; cases received BIPAP/NIV during hospitalization were documented normal and abnormal ferritin level in 155/445 and 165/235 cases, respectively (p < 0.00001). Timing of BIPAP/NIV requirement during course of COVID-19 pneumonia in critical care setting has significant association with ferritin level; cases received BIPAP/NIV at entry point < 1 day, 3–7 days, and after 7 days of hospitalization were documented significance in fourfold raised ferritin level in 110/70, 150/160, and 30/80 cases, respectively (p < 0.00001). Follow-up of ferritin titer during hospitalization as compared to entry point abnormal ferritin has significant association in post-COVID lung fibrosis (p < 0.00001). Follow-up of ferritin titer during hospitalization as compared to entry point normal ferritin has significant association in post-COVID lung fibrosis (p < 0.00001). Ferritin is easily available, sensitive and reliable, cost-effective, and universally acceptable inflammatory marker in COVID-19 pandemic. Ferritin has very crucial role in COVID-19 pneumonia in predicting severity of illness and assessing response to treatment during hospitalization. Follow-up of ferritin titer during hospitalization and at discharge can be used as early predictor of post-COVID lung fibrosis.

Tài liệu tham khảo

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports [Accessed on 24 Dec 2021] Lippi G, Plebani M (2020) The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clin Chem Lab Med. 58(7):1063–1069. https://doi.org/10.1515/cclm-2020-0240 PMID: 32191623 Bohn MK, Lippi G, Horvath A, Sethi S, Koch D, Ferrari M, Wang C-B, Mancini N, Steele S, Adeli K (2020) Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence. Clin. Chem. Lab. Med. 58:1037–1052. https://doi.org/10.1515/cclm-2020-0722 Zhou F, et al (2020) Lancet clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062 Robba C, Battaglini D, Pelosi P, et al (2020) Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2. Expert Rev. Respir. Med. 14(9):865–868 Mehta P, McAuley DF, Brown M, et al (2020) HLH across speciality collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033–1034 Alunno A, Carubbi F, Rodríguez-Carrio J (2020) Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin. RMD Open. 6(1):e001295. https://doi.org/10.1136/rmdopen-2020-001295 Ruan Q, et al (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan. China. Intensive Care Med 46(5):846–848 Abbaspour N, Hurrell R, Kelishadi R (2014) Review on iron and its importance for human health. Res J Med Sci. 19(2):164–174 Wang Z, Du Z, Zhu F (2020) Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Diabetes Res Clin Pract. 164:108214 Ma A, Jia R, Ma X, Sun Y, Zhang H, Ma Y (2016) Iron storage in women is positively correlated with aging and BMI values. Energy Nutr Metab. 30(S1):377–382 Wu J, Liu J, Zhao X, et al (2020) Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multicenter descriptive study. Clin Infect Dis. 71(15):706–712 Kömürcüoğlu B, Ozgur B, Bilge S, Seher S (2021) Karadeniz Gulistan Correlation between chest CT severity scores and clinical and biochemical parameters of COVID-19 pneumonia. Eur Respir J 58(Suppl. 65):PA3646 Dahan S, Segal G, Katz I, Hellou T, Tietel M, Bryk G, Amital H, Shoenfeld Y, Dagan A (2020) Ferritin as a marker of severity in COVID-19 patients: a fatal correlation. Isr Med Assoc J. 22(8):494–500 PMID: 33236582 Quirit AM, Sorreda J, Pinera R, Tobias KK (2021) Serum ferritin level as a prognostic marker of 30 days in hospital mortality of coronavirus disease 2019 (COVID 19) pneumonia at World Citi Medical Center: a retrospective, observational cohort, single center study. Int J Coronaviruses 3(3):20–29 Zhou P, Yang XL, Wang XG, et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270–273. https://doi.org/10.1038/s41586-020-2012-7 Alroomi M, Rajan R, Omar AA, Alsaber A, Pan J, Fatemi M, et al (2021) Ferritin level: a predictor of severity and mortality in hospitalized COVID-19 patients. Immun Inflamm Dis 9(4):1648–1655. https://doi.org/10.1002/iid3.517 Epub 2021 Aug 26. PMID: 34438471; PMCID: PMC8589386 Del Valle DM, Kim-Schulze S, Huang HH, Beckmann ND, Nirenberg S, Wang B, et al (2020) An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med 26(10):1636–1643. https://doi.org/10.1038/s41591-020-1051-9 Huang S, Wang J, Liu F, et al (2020) COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study. Hypertens Res 43:824–831. https://doi.org/10.1038/s41440-020-0485-2 Montecino-rodriguez E, Berent-maoz B, Dorshkind K, Montecino-rodriguez E, Berent-maoz B, Dorshkind K (2013) Causes, consequences, and reversal of immune system aging find the latest version: review series causes, consequences, and reversal of immune system aging. J Clin Investigation 123(3):958–965. https://doi.org/10.1172/JCI64096 Dhont S, Derom E, Van Braeckel E, et al (2020) The pathophysiology of ‘happy’ hypoxemia in COVID-19. Respir Res 21:198. https://doi.org/10.1186/s12931-020-01462-5 Wu C, Chen X, Cai Y, et al (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China [published correction appears in JAMA Intern Med. 2020 Jul 1;180(7):1031]. JAMA Intern Med. 180(7):934–943. https://doi.org/10.1001/jamainternmed.2020.0994 Fox SE, Akmatbekov A, Harbert JL, et al Pulmonary and cardiac pathology in COVID-19: the first autopsy series from New Orleans. Lancet Respir Med. https://doi.org/10.1016/s2213-2600(20)30243-5 Meloni M, Izzo V, Giurato L, Brocco E, Ferrannini M, Gandini R, Uccioli L (2019. Article ID 4312737) Procalcitonin is a prognostic marker of hospital outcomes in patients with critical limb ischemia and diabetic foot infection. J Diabetes Res 2019:5. https://doi.org/10.1155/2019/4312737 Rasyid H, Sangkereng A, Harjianti T, Soetjipto AS (2021) Impact of age to ferritin and neutrophil-lymphocyte ratio as biomarkers for intensive care requirement and mortality risk in COVID-19 patients in Makassar, Indonesia. Physiol Rep. 9(10):e14876. https://doi.org/10.14814/phy2.14876 PMID: 34042296; PMCID: PMC8157771 Samreen S, Quratulain S, Syed S, Anum R, Fivzia H, et al (2021) Determinants of in-hospital mortality in COVID-19; a prospective cohort study from Pakistan. PLOS One 16:0251754 Ho FK, Petermann-Rocha F, Gray SR, Jani BD, Katikireddi SV, Niedzwiedz CL, et al (2020) Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants. PLoS One 15(11):1–11. https://doi.org/10.1371/journal.pone.0241824 Liu D, Zhang W, Pan F, Li L, Yang L, Zheng D, et al (2020) The pulmonary sequalae in discharged patients with COVID-19: a short-term observational study. Respir Res. 21(1):125 Yasin R, Gomaa AAK, Ghazy T, et al (2021) Predicting lung fibrosis in post-COVID-19 patients after discharge with follow-up chest CT findings. Egypt J Radiol Nucl Med 52:118. https://doi.org/10.1186/s43055-021-00495-0 Yu M, Liu Y, Xu D, Zhang R, Lan L, Xu H (2020) Prediction of the development of pulmonary fibrosis using serial thin-section CT and clinical features in patients discharged after treatment for COVID-19 pneumonia. Korean J Radiol 21(6):746–755 Ruan Q, Yang K, Wang W, Jiang L, Song J, (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 46(5):846–848. https://doi.org/10.1007/s00134-020-05991-x Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Apr 6;: PMID: 32125452; PMCID: PMC7080116 Lin Z, Long F, Yang Y, Chen X, Xu L, Yang M (2020) Serum ferritin as an independent risk factor for severity in COVID-19 patients. J Infect. 81(4):647–679. https://doi.org/10.1016/j.jinf.2020.06.053 Zhou F, Ting Y, Ronghui D, Fan G, Liu Y, Liu Z, et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054–1062 Gandini O, Criniti A, Ballesio L, Giglio S, Galardo G, Gianni W, et al (2020) Serum ferritin is an independent risk factor for acute respiratory distress syndrome in COVID-19. J Infect 81(6):979–997. https://doi.org/10.1016/j.jinf.2020.09.006 Epub 2020 Sep 15. PMID: 32946917; PMCID: PMC7490639 Yan L, Zhang H-T, Goncalves J, Xiao Y, Wang M, Guo Y, et al (2020) An interpretable mortality prediction model for COVID-19 patients. Nat Mach Intell. 2:283–288 Ye Z, Zhang Y, Wang Y, Huang Z, Song B (2020) Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol 30(8):4381–4389. https://doi.org/10.1007/s00330-020-06801-0 Epub 2020 Mar 19. PMID: 32193638; PMCID: PMC7088323 Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8(4):420–422. https://doi.org/10.1016/S2213-2600(20)30076-X Epub 2020 Feb 18. Erratum in: Lancet Respir Med. 2020 Feb 25;: PMID: 32085846; PMCID: PMC7164771 Song F, Shi N, Shan F, Zhang Z, Shen J, Hongzhou L, et al (2020) Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology 295(1):210–217 Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al (2020) Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology 295(3):715–721. https://doi.org/10.1148/radiol.2020200370 Epub 2020 Feb 13. PMID: 32053470; PMCID: PMC7233367 Shi H, Han X, Jiang N, Cao Y, Alwalid O, Jin G, et al (2020) Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect. Dis. 20(4):425–434